We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,177 hedge funds and large institutions have $75.1B invested in Regeneron Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 401 increasing their positions, 446 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 111 | Existing positions closed: 87

13% more capital invested

Capital invested by funds: $66.2B → $75.1B (+$8.91B)

4% more funds holding in top 10

Funds holding in top 10: 28 → 29 (+1)

1% more funds holding

Funds holding: 1,165 → 1,177 (+12)

0.39% less ownership

Funds ownership: 85.84% → 85.45% (-0.39%)

10% less repeat investments, than reductions

Existing positions increased: 401 | Existing positions reduced: 446

11% less call options, than puts

Call options by funds: $1.43B | Put options by funds: $1.61B

Holders
1,177
Holders Change
+12
Holders Change %
+1.03%
% of All Funds
18.68%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.46%
New
111
Increased
401
Reduced
446
Closed
87
Calls
$1.43B
Puts
$1.61B
Net Calls
-$183M
Net Calls Change
+$45.7M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$664M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$526M
3
WP
Woodline Partners
California
+$69.9M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$64.9M
5
ZIG
Zurich Insurance Group
Switzerland
+$62.3M

Top Sellers

1
EWA
EP Wealth Advisors
California
-$446M
2
Capital World Investors
Capital World Investors
California
-$348M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$248M
4
BlackRock
BlackRock
New York
-$166M
5
Invesco
Invesco
Georgia
-$130M
Name Holding Trade Value Shares
Change 		Change in
Stake
CPG
1176
Cornerstone Planning Group
New Jersey
$823 +$786 +1 New
IPW
1177
Impact Partnership Wealth
Georgia
$823 +$786 +1 New
PCFFS
1178
Pacific Center for Financial Services
California
$11 – – –
Alyeska Investment Group
1179
Alyeska Investment Group
Illinois
– -$80.6M -112,238 Closed
MF
1180
Magnetar Financial
Illinois
– -$49.1M -68,320 Closed
AAM
1181
Ardevora Asset Management
United Kingdom
– -$48.6M -67,614 Closed
BC
1182
Brookfield Corp
Ontario, Canada
– -$21.3M -29,626 Closed
Walleye Capital
1183
Walleye Capital
New York
– -$17M -21,673 Closed
JAM
1184
Jupiter Asset Management
United Kingdom
– -$14.3M -19,964 Closed
VIA
1185
Vident Investment Advisory
Georgia
– -$11.2M -15,634 Closed
BFM
1186
Boothbay Fund Management
New York
– -$7.61M -10,590 Closed
VF
1187
Virtu Financial
New York
– -$6.78M -9,431 Closed
EOJOAM
1188
E. Ohman J:or Asset Management
Sweden
– -$6.7M -9,329 Closed
GCM
1189
Gladius Capital Management
Illinois
– -$5.86M -8,150 Closed
LG
1190
Leuthold Group
Minnesota
– -$3.71M -5,157 Closed
Walleye Trading
1191
Walleye Trading
New York
– -$3.74M -4,764 Closed
PFM
1192
Patton Fund Management
Texas
– -$2.92M -4,068 Closed
HVM
1193
Harvest Volatility Management
Connecticut
– -$2.39M -3,326 Closed
ECM
1194
ExodusPoint Capital Management
New York
– -$2.05M -2,858 Closed
BCM
1195
Bridgeway Capital Management
Texas
– -$1.87M -2,600 Closed
Twin Tree Management
1196
Twin Tree Management
Texas
– -$1.82M -2,532 Closed
CIA
1197
Cascade Investment Advisors
Oregon
– -$1.63M -2,275 Closed
YIH
1198
Y-Intercept (HK)
Hong Kong
– -$1.6M -2,221 Closed
V
1199
Veritable
Delaware
– -$1.56M -2,178 Closed
GECH
1200
Garnet Equity Capital Holdings
New York
– -$1.44M -2,000 Closed
46 47
48
49 50

REGN Hedge Fund Activity: Q3 2023 in Review

1,177 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q3 2023, worth a combined $75.1B — up 13% from $66.2B a quarter earlier.

Buyers outnumbered sellers: 111 funds opened new REGN positions and 87 closed out — a net gain of 24 holders — while 401 added to existing stakes and 446 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $664M. The largest seller was EP Wealth Advisors, cutting an estimated $446M.

  • 1,177 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q3 2023, up from 1,165 in Q2 2023.
  • Funds reported $75.1B of Regeneron Pharmaceuticals stock for Q3 2023, up 13% quarter-over-quarter.
  • 111 funds opened new Regeneron Pharmaceuticals positions in Q3 2023 and 87 closed out, a net change of +24 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q3 2023 was JP Morgan Chase, an estimated $664M added.
  • The largest Regeneron Pharmaceuticals seller in Q3 2023 was EP Wealth Advisors, an estimated $446M sold.

Based on aggregated 13F filings for Q3 2023.